MD HB1132 | 2024 | Regular Session
Status
Spectrum: Partisan Bill (Republican 6-0)
Status: Introduced on February 7 2024 - 25% progression, died in chamber
Action: 2024-03-04 - Withdrawn by Sponsor
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 7 2024 - 25% progression, died in chamber
Action: 2024-03-04 - Withdrawn by Sponsor
Text: Latest bill text (Introduced) [PDF]
Summary
Authorizing pharmaceutical manufacturers and representatives of pharmaceutical manufacturers to engage in the truthful promotion of off-label uses for drugs, biological products, and devices; and prohibiting certain persons from taking certain enforcement and disciplinary action against a pharmaceutical manufacturer, representative of a pharmaceutical manufacturer, or health care provider for engaging in a truthful promotion of an off-label use of a drug, biological product, or device.
Title
Drugs, Biological Products, and Devices - Off-Label Use - Promotion
Sponsors
Del. Matt Morgan [R] | Del. Lauren Arikan [R] | Del. Brian Chisholm [R] | Del. Robin Grammer [R] |
Del. Susan McComas [R] | Del. Ryan Nawrocki [R] |
History
Date | Chamber | Action |
---|---|---|
2024-03-04 | House | Withdrawn by Sponsor |
2024-02-28 | House | Hearing canceled |
2024-02-09 | House | Hearing 2/29 at 1:00 p.m. |
2024-02-07 | House | First Reading Health and Government Operations |
Subjects
Drugs
Ethics
Health
Health Occupations
Industry and Technology
Labeling
Public Health
Rules and Regulations
Safety
Ethics
Health
Health Occupations
Industry and Technology
Labeling
Public Health
Rules and Regulations
Safety
Code Citations
Chapter | Article | Section | Citation Type | Statute Text |
---|---|---|---|---|
Health - General | 21 | 218.1 | (n/a) | See Bill Text |